Biolight Life Sciences Ltd. (BOLT)
TASE
271.90
+7.30 (+2.76%)
Closed
Aug 25, 2026
Day's Range
264.60279.70
52 wk Range
5.19542.10
Financial Statements - BOLT - Biolight Life Sciences Ltd.
Revenue
0▼ 100.0%
Net Income
-16.91M▼ 100.7%
EBITDA
-15.03M▼ 46.5%
Free Cash Flow
-10.85M▲ 1.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 219K | 118K | 63K | 3K | 31K |
| Cost of Goods | - | - | - | - | - | 0 |
| Gross Profit | - | - | 118K | 63K | - | 31K |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -15.20M | -10.11M | -10.65M | -10.32M | -10.60M | -11.32M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -16.91M | -8.42M | -27.48M | -8.68M | -1.91M | -14.03M |
| Income Tax | - | - | 0 | 0 | -1.57M | 135K |
| Net Income | -16.91M | -8.42M | -27.48M | -8.68M | -339K | -15.08M |
| EPS Basic | -1.98 | -1.53 | -5.6 | -1.72 | 0.08 | -2.95 |
| EPS Diluted | -1.98 | -1.53 | -5.6 | -1.72 | 0.08 | -2.95 |
| Basic Shares Outstanding | 5.92M | 4.65M | 4.64M | 4.56M | 4.55M | 4.54M |
| Diluted Shares Outstanding | 5.92M | 4.65M | 4.64M | 4.56M | 4.55M | 4.54M |
| Ebit | -16.83M | -8.34M | -27.41M | -8.62M | -1.88M | -14.02M |
| Ebitda | -15.03M | -10.26M | -10.23M | -9.71M | -11.15M | -12.03M |
| Net Income Continuous Operations | -16.91M | -8.42M | -27.48M | -8.68M | -27.48M | -15.08M |
| Minority Interests | 5.18M | 1.28M | 1.46M | 840K | 721K | 1.70M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
